57857
Lithium iodoacetate
≥97.0% (NT)
Synonym(s):
Iodoacetic acid lithium salt
Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
About This Item
Linear Formula:
ICH2COOLi
CAS Number:
Molecular Weight:
191.88
UNSPSC Code:
12352103
NACRES:
NA.25
PubChem Substance ID:
EC Number:
265-905-7
Beilstein/REAXYS Number:
4208524
MDL number:
Assay:
≥97.0% (NT)
Quality Level
assay
≥97.0% (NT)
impurities
≤3% water
mp
239 °C (dec.) (lit.), ~245 °C (dec.)
SMILES string
[Li+].[O-]C(=O)CI
InChI
1S/C2H3IO2.Li/c3-1-2(4)5;/h1H2,(H,4,5);/q;+1/p-1
InChI key
RZCFQIDTJPHHFJ-UHFFFAOYSA-M
Application
Lithium iodoacetate, a halogenacetate, is a lithium salt of iodoacetate that may be used in the study of cysteine peptidases.
Other Notes
Sales restrictions may apply
Disclaimer
May discolor to yellow on storage
signalword
Warning
Hazard Classifications
Acute Tox. 4 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3
target_organs
Respiratory system
Storage Class
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
dust mask type N95 (US), Eyeshields, Gloves
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Ehrenberg et al.
Acta crystallographica. Section B, Structural science, 55(Pt 4), 517-524 (2000-08-06)
Most halogenoacetates of alkali salts readily undergo a thermally induced polymerization reaction to poly-(hydroxyacetic acid) in the solid state. The lithium salts represent a remarkable exception. The crystal structures of lithium chloroacetate, lithium bromoacetate and lithium iodoacetate were determined ab
Yun Ju Woo et al.
Experimental & molecular medicine, 43(10), 561-570 (2011-07-29)
Osteoarthritis (OA) is an age-related joint disease that is characterized by degeneration of articular cartilage and chronic pain. Oxidative stress is considered one of the pathophysiological factors in the progression of OA. We investigated the effects of grape seed proanthocyanidin
Sébastien Goutal et al.
Drug delivery and translational research, 8(3), 536-542 (2018-01-03)
Elacridar (GF120918) is a highly potent inhibitor of both P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2), the main efflux transporters expressed at the blood-brain barrier (BBB). Elacridar shows very low aqueous solubility, which complicates its formulation for i.v. administration.
Global Trade Item Number
| SKU | GTIN |
|---|---|
| 57857-50G-F | 04061832860398 |
| 57857-1KG-F | 04061832629223 |